
Insulet Corporation PODD
€ 255.37
1.36%
Quartalsbericht 2025-Q3
hinzugefügt 06.12.2025
Insulet Corporation Operativer Cashflow 2011-2026 | PODD
Operativer Cashflow Jährlich Insulet Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 430 M | 146 M | 119 M | -68.1 M | 84 M | 98.4 M | 35.9 M | 41.3 M | 15.9 M | -12.6 M | 8.92 M | 3.35 M | -29.1 M | -25.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 430 M | -68.1 M | 60.5 M |
Operativer Cashflow Vierteljährlich Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 63.8 M | - | - | - | 87.6 M | - | - | - | 500 K | - | - | - | -13.7 M | - | - | - | -35.1 M | - | 67 M | 22.8 M | -3.6 M | - | 51.5 M | 20.4 M | 6.5 M | - | 5.46 M | -10.4 M | -4.27 M | - | 19.4 M | -3.87 M | -21.8 M | - | -4.16 M | -6.84 M | -10.5 M | - | 6.04 M | -2.7 M | -3.49 M | - | 4.31 M | -509 K | -1.02 M | - | 6.87 M | 3.17 M | -1.2 M | - | -23.5 M | -20 M | -8.9 M | - | -17.8 M | -16.9 M | -7.87 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 87.6 M | -35.1 M | 4.21 M |
Operativer Cashflow anderer Aktien in der Medizinische Geräte
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
Abiomed
ABMD
|
275 M | - | - | $ 17.2 B | ||
|
Cognyte Software Ltd.
CGNT
|
46.8 M | $ 9.54 | 2.03 % | $ 685 M | ||
|
AxoGen
AXGN
|
4.54 M | $ 32.81 | 5.67 % | $ 1.45 B | ||
|
Alphatec Holdings
ATEC
|
-44.7 M | $ 21.96 | 0.76 % | $ 3.14 B | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
-5.25 M | $ 3.47 | -2.49 % | $ 120 M | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.75 | -0.79 % | $ 140 M | ||
|
Bio-Rad Laboratories
BIO
|
455 M | $ 323.35 | -0.66 % | $ 9.12 B | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
3.44 B | $ 98.56 | 0.8 % | $ 145 B | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
251 M | $ 53.03 | 0.68 % | $ 7.9 K | ||
|
CONMED Corporation
CNMD
|
167 M | $ 43.31 | -0.39 % | $ 1.34 B | ||
|
Abbott Laboratories
ABT
|
8.56 B | $ 126.93 | -0.69 % | $ 221 B | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | ||
|
InMode Ltd.
INMD
|
133 M | $ 15.62 | 0.36 % | $ 1.24 B | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
11.4 M | $ 29.03 | 2.25 % | $ 245 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
-20.8 M | - | -0.97 % | $ 54.4 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
Align Technology
ALGN
|
738 M | $ 166.78 | -0.52 % | $ 12.5 B | ||
|
Accuray Incorporated
ARAY
|
2.86 M | $ 0.88 | -1.53 % | $ 90.4 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-8.95 M | $ 15.3 | 0.22 % | $ 414 M | ||
|
Profound Medical Corp.
PROF
|
-22.4 M | $ 8.18 | 5.82 % | $ 180 M | ||
|
FONAR Corporation
FONR
|
15.3 M | $ 18.55 | 0.03 % | $ 122 M | ||
|
Globus Medical
GMED
|
521 M | $ 90.47 | -3.03 % | $ 12.3 B | ||
|
IRIDEX Corporation
IRIX
|
-6.74 M | $ 1.19 | 0.85 % | $ 19.2 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
129 M | $ 13.05 | -0.61 % | $ 1 B | ||
|
IRadimed Corporation
IRMD
|
25.6 M | $ 97.9 | -0.17 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-21.8 M | - | 1.37 % | $ 20.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-27 M | $ 18.33 | -2.19 % | $ 423 M | ||
|
Establishment Labs Holdings
ESTA
|
-58.5 M | $ 69.6 | 0.4 % | $ 1.96 B | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M |